Reply to: The JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis. by Kremer M et alOHYASHIKI, K; OHYASHIKI, J. H.Leukemia. 2006, Vol 20, Num 7, pp 1297-1298, issn 0887-6924, 2 p.Article

Analysis of DNA from cells fixed in Carnoy's solution for cytogenetic studyOHYASHIKI, J. H; OHYASHIKI, K; TOYAMA, K et al.Cancer genetics and cytogenetics. 1988, Vol 34, Num 2, pp 159-163, issn 0165-4608Article

Cytogenetic characterization of putative human myeloblastic leukemia cell lines (ML-1, -2, and -3): origin of the cellsOHYASHIKI, K; OHYASHIKI, J. H; SANDBERG, A. A et al.Cancer research (Baltimore). 1986, Vol 46, Num 7, pp 3642-3647, issn 0008-5472Article

Morphologic changes of neutrophils in myelodysplastic syndrome treated with recombinant human granulocyte colony-stimulating factorTOYAMA, K; OHYASHIKI, K; OHYASHIKI, J. H et al.Japanese journal of cancer research. 1988, Vol 79, Num 7, pp 813-816, issn 0910-5050Article

A nonradioactive, fluorescence-based telomeric repeat amplification protocol to detect and quantitate telomerase activityOHYASHIKI, J. H; OHYASHIKI, K; TOYAMA, K et al.Trends in genetics (Regular ed.). 1996, Vol 12, Num 10, pp 395-396, issn 0168-9525Article

Non-radioisotopic and semi-quantitative procedure for terminal repeat amplification protocolOHYASHIKI, J. H; OHYASHIKI, K; SANO, T et al.Japanese journal of cancer research. 1996, Vol 87, Num 4, pp 329-331, issn 0910-5050Article

Do leukemia patients with chromosome 16 inversion-inv (16) (p13q22) ― Have a rare fragile site at 16q22?OHYASHIKI, K; OHYASHIKI, J. H; TOYAMA, K et al.Cancer genetics and cytogenetics. 1988, Vol 31, Num 1, pp 31-34, issn 0165-4608Article

Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infectionZHANG, Y; OHYASHIKI, J. H; TAKAKU, T et al.British journal of cancer. 2006, Vol 94, Num 4, pp 599-608, issn 0007-0920, 10 p.Article

A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemiaSUMI, M; TAUCHI, T; SASHIDA, G et al.International journal of oncology. 2004, Vol 24, Num 6, pp 1481-1487, issn 1019-6439, 7 p.Article

Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapyNAKAJIMA, A; TAUCHI, T; SASHIDA, G et al.Leukemia. 2003, Vol 17, Num 3, pp 560-567, issn 0887-6924, 8 p.Article

Soluble CD44 level in non-malignant disorders is associated with autoimmune backgroundsOHYASHIKI, K; ANDO, K; HAYASHI, S et al.Autoimmunity (Print). 1999, Vol 30, Num 1, pp 35-36, issn 0891-6934Article

Late appearance of t(5;12)(q31;p12) in acute myeloid leukemia associated with eosinophiliaYAHATA, N; OHYASHIKI, K; OHYASHIKI, J. H et al.Cancer genetics and cytogenetics. 1998, Vol 107, Num 2, pp 147-150, issn 0165-4608Article

Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assayOHYASHIKI, K; OHYASHIKI, J. H; NISHIMAKI, J et al.Cancer research (Baltimore). 1997, Vol 57, Num 11, pp 2100-2103, issn 0008-5472Article

Double-minute chromosomes appearing in a patient with myelodysplastic syndrome with disease evolutionOHYASHIKI, K; MURAKAMI, T; OHYASHIKI, J. H et al.Cancer genetics and cytogenetics. 1995, Vol 79, Num 2, pp 169-172, issn 0165-4608Article

Late appearance of a Philadelphia translocation with minor-BCR/ABL transcript in a t(7;11)(p15;p15) acute myeloid leukemiaSHIMAMOTO, T; OHYASHIKI, K; OHYASHIKI, J. H et al.Leukemia. 1995, Vol 9, Num 4, pp 640-642, issn 0887-6924Article

Clinical and biologic characteristics of CD7⁺ acute myeloid leukemia : our experience and literature reviewSHIMAMOTO, T; OHYASHIKI, J. H; OHYASHIKI, K et al.Cancer genetics and cytogenetics. 1994, Vol 73, Num 1, pp 69-74, issn 0165-4608Article

EVI1 expression associated with a 3q26 anomaly in a leukemia cell line derived from the blast crisis of chronic myeloid leukemiaOHYASHIKI, K; OHYASHIKI, J. H; FUJIEDA, H et al.Leukemia. 1994, Vol 8, Num 12, pp 2169-2173, issn 0887-6924Article

Telomere shortening in leukemic cells is related to their genetic alterations but not replicative capabilityOHYASHIKI, K; OHYASHIKI, J. H; FUJIMURA, T et al.Cancer genetics and cytogenetics. 1994, Vol 78, Num 1, pp 64-67, issn 0165-4608Article

Translocation t(3;4)(q26;q21) in myelodysplastic syndrome with megakaryoblastic proliferationOHYASHIKI, K; ENOMOTO, Y; WATANABE, Y et al.Cancer genetics and cytogenetics. 1988, Vol 34, Num 1, pp 5-9, issn 0165-4608Article

Cytogenetic changes at 11q11, 11q23, and 17q11 in myelodysplastic syndromeOHYASHIKI, K; YOSHIDA, M. A; GIBAS, L. M et al.Cancer genetics and cytogenetics. 1986, Vol 21, Num 4, pp 287-295, issn 0165-4608Article

Cytogenetic findings in a malignant melanoma and its derived cell lineOHYASHIKI, J. H; OHYASHIKI, K; GIBAS, Z et al.Cancer genetics and cytogenetics. 1986, Vol 23, Num 1, pp 77-85, issn 0165-4608Article

Thrombosis can occur at any phase of essential thrombocythemia with JAK2^V617F mutation : a single institutional study in JapanOHYASHIKI, K; ITO, Y; HORI, K et al.Leukemia. 2007, Vol 21, Num 7, pp 1570-1571, issn 0887-6924, 2 p.Article

Identification and functional signature of genes regulated by structurally different ABL kinase inhibitorsNUNODA, K; TAUCHI, T; TAKAKU, T et al.Oncogene (Basingstoke). 2007, Vol 26, Num 28, pp 4179-4188, issn 0950-9232, 10 p.Article

A rapid monitoring system of human herpesviruses reactivation by LightCycler in stem cell transplantationARITAKI, K; OHYASHIKI, J. H; SUZUKI, A et al.Bone marrow transplantation (Basingstoke). 2001, Vol 28, Num 10, pp 975-980, issn 0268-3369Article

Clinical and cytogenetic significance of myelodysplastic syndromes with disease evolutionOHYASHIKI, K; IWABUCHI, A; SASAO, I et al.Cancer genetics and cytogenetics. 1993, Vol 67, Num 1, pp 71-79, issn 0165-4608Article